Online citations, reference lists, and bibliographies.

Neutralization Of Animal Virus Infectivity By Antibody

Steven A Reading, Nigel J. Dimmock
Published 2006 · Medicine, Biology
Cite This
Download PDF
Analyze on Scholarcy
Share
SummaryNeutralization is the ability of antibody to bind to and inactivate virus infectivity under defined conditions in vitro. Most neutralizing antibodies also protect animals in vivo, but protection is more complex as it also involves interaction of antibody with cells and molecules of the innate immune system. Neutralization by antibody can be mediated by a number of different mechanisms: by aggregation of virions, destabilization of the virion structure, inhibition of virion attachment to target cells, inhibition of the fusion of the virion lipid membrane with the membrane of the host cell, inhibition of the entry of the genome of non-enveloped viruses into the cell cytoplasm, inhibition of a function of the virion core through a signal transduced by an antibody, transcytosing IgA, and binding to nascent virions to block their budding or release from the cell surface. The mechanism of neutralization is determined by the properties of both a virion epitope and the antibody that reacts with it. Further, since a virus has at least several unique epitopes sited in different locations on the virion, and since the paratope and other properties of the reacting antibody can vary, this means that a virus can be neutralized by several different mechanisms. Understanding the processes of neutralization informs the creation of modern vaccines, and gives valuable insights into virus-cell interactions.
This paper references
10.1016/0042-6822(83)90154-X
Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry.
J. Icenogle (1983)
10.1128/jvi.67.3.1148-1158.1993
Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody.
Thomas Smith (1993)
10.1007/978-3-642-77849-0
Neutralization of Animal Viruses
Nigel J. Dimmock (1993)
10.1128/JVI.75.21.10208-10218.2001
Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.
Marshall J. Edwards (2001)
10.1016/0042-6822(87)90466-1
Quantitative relationships between an influenza virus and neutralizing antibody.
Hailey Taylor (1987)
An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection.
Marshall R. Posner (1991)
10.1016/S0042-6822(03)00533-6
A novel monoclonal antibody specific to the C-terminal tail of the gp41 envelope transmembrane protein of human immunodeficiency virus type 1 that preferentially neutralizes virus after it has attached to the target cell and inhibits the production of infectious progeny.
Steven A Reading (2003)
10.1128/jvi.72.5.3512-3519.1998
Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity.
Paul W H I Parren (1998)
10.1073/pnas.91.9.3809
In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity.
Carlos F. Barbas (1994)
10.1128/jvi.62.12.4594-4604.1988
Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing).
Herbert W. Virgin (1988)
10.1128/jvi.62.8.2762-2772.1988
Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions.
Suzanne L. Zebedee (1988)
10.1128/jvi.67.7.3978-3988.1993
Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding.
Markus Thali (1993)
Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody
TJ Smith (1993)
10.1128/jvi.54.1.7-13.1985
A monoclonal antibody that neutralizes poliovirus by cross-linking virions.
Adri A. M. Thomas (1985)
10.1128/jvi.65.6.3001-3006.1991
Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection.
K. E. Wright (1991)
10.1006/viro.1993.1261
Mechanisms of rabies virus neutralization.
Anne Flamand (1993)
10.1007/BF01314281
Neutralization of poliovirus by polyclonal antibodies requires binding of a single IgG molecule per virion
Klaus Wetz (2005)
10.1016/0968-0004(87)90034-X
Multiple mechanisms of neutralization of animal viruses
Nigel J. Dimmock (1987)
10.1099/0022-1317-83-9-2091
Occupancy and mechanism in antibody-mediated neutralization of animal viruses.
Per Johan Klasse (2002)
10.1093/emboj/16.6.1189
Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization.
Patrick L. Stewart (1997)
10.1128/JVI.80.2.891-899.2006
Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.
Zhongyu Zhu (2006)
10.1006/viro.1999.0041
Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
Stephanie Cleveland (2000)
10.1099/0022-1317-70-8-2097
IgG-neutralized influenza virus undergoes primary, but not secondary uncoating in vivo.
R J Rigg (1989)
10.1006/viro.1997.8547
A human IgG1 (b12) specific for the CD4 binding site of HIV-1 neutralizes by inhibiting the virus fusion entry process, but b12 Fab neutralizes by inhibiting a postfusion event.
T L McInerney (1997)
10.1128/jvi.66.6.3823-3832.1992
Neutralization of influenza virus by low concentrations of hemagglutinin-specific polymeric immunoglobulin A inhibits viral fusion activity, but activation of the ribonucleoprotein is also inhibited.
Susan J Armstrong (1992)
10.1099/vir.0.80414-0
An antibody specific for the C-terminal tail of the gp41 transmembrane protein of human immunodeficiency virus type 1 mediates post-attachment neutralization, probably through inhibition of virus-cell fusion.
Caroline J Heap (2005)
10.1128/jvi.63.5.2081-2087.1989
Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody.
Robert S. Fujinami (1989)
10.1084/jem.161.1.198
Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG
Hailey Taylor (1985)
10.1073/pnas.89.15.7252
Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system.
Bernhard Dietzschold (1992)
10.1099/0022-1317-66-12-2773
Two monoclonal antibodies against La Crosse virus show host-dependent neutralizing activity.
Leo J. Grady (1985)
10.1099/0022-1317-79-11-2709
The neutralizing antibody response against a conserved region of human immunodeficiency virus type 1 gp41 (amino acid residues 731-752) is uniquely directed against a conformational epitope.
Emanuele Buratti (1998)
10.1006/viro.1997.8932
Inhibition of HIV-1 replication by a monoclonal antibody directed toward the complementarity determining region 3-like domain of CD4 in CD45 expressing and CD45-deficient cells.
Annick Péléraux (1998)
10.1128/jvi.71.6.4847-4851.1997
Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization.
Carlo Rizzuto (1997)
Conformational alteration in foot-and-mouth disease virus virion capsid structure after complexing with monospecific antibody.
K. C. Mccullough (1987)
10.1016/0042-6822(83)90159-9
Neutralization of poliovirus by antibody-mediated polymerization.
P. Brioen (1983)
Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus.
Robert G Webster (1967)
10.1016/S0022-2836(03)00611-9
Structural analysis of the epitope of the anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion.
Gaetano Barbato (2003)
10.1099/0022-1317-78-10-2431
Variations in the neutralizing and haemagglutination-inhibiting activities of five influenza A virus-specific IgGs and their antibody fragments.
Darren J Schofield (1997)
10.2174/1568005054201535
HIV-1: the confounding variables of virus neutralization.
Peter Lloyd Nara (2005)
10.1128/jvi.69.2.1339-1343.1995
Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies.
Mary B. Mazanec (1995)
10.1099/0022-1317-58-2-373
Studies on the mechanism of neutralization of influenza virus by antibody: evidence that neutralizing antibody (anti-haemagglutinin) inactivates influenza virus in vivo by inhibiting virion transcriptase activity.
Robert D. Possee (1982)
10.1016/0168-1702(89)90019-1
Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent viral attachment.
Ronald M. Iorio (1989)
10.1128/JVI.02625-05
Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type 1 replication in macrophages and immature dendritic cells.
Vincent Holl (2006)
10.1111/j.1348-0421.2005.tb03663.x
Further studies on the mechanism of rabies virus neutralization by a viral glycoprotein-specific monoclonal antibody, #1-46-12.
Takashi Irie (2005)
10.1099/0022-1317-66-11-2495
Hit-and-run neutralization of poliovirus.
P. Brioen (1985)
10.1016/S0065-3527(08)60101-3
Neutralization of Animal Viruses
Benjamin Mandel (1978)
10.1073/pnas.89.15.6901
Intracellular neutralization of virus by immunoglobulin A antibodies.
Mary B. Mazanec (1992)
10.1128/JVI.74.20.9381-9387.2000
Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles.
Donald J Wyma (2000)
10.1099/0022-1317-73-8-1995
Mechanisms of neutralization of a nairovirus (Dugbe virus) by polyclonal IgG and IgM.
E M Green (1992)
10.1099/0022-1317-38-1-1
A multi-hit model for the neutralization of animal viruses.
A. J. Della‐Porta (1978)
10.1016/S0065-2776(01)77018-6
The antiviral activity of antibodies in vitro and in vivo
Paul W H I Parren (2001)
10.1128/JVI.79.19.12311-12320.2005
Kinetic rates of antibody binding correlate with neutralization sensitivity of variant simian immunodeficiency virus strains.
Jonathan D. Steckbeck (2005)
10.1128/jvi.59.2.479-485.1986
Relationship between poliovirus neutralization and aggregation.
Adri A. M. Thomas (1986)
10.1007/978-3-662-05783-4_7
A model for neutralization of viruses based on antibody coating of the virion surface.
D R Burton (2001)
10.1128/jvi.62.7.2321-2328.1988
Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms.
C E Wohlfart (1988)
10.1002/rmv.419
Valency of antibody binding to virions and its determination by surface plasmon resonance.
Nigel J. Dimmock (2004)
10.1128/jvi.70.6.3668-3677.1996
Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1.
Per Johan Klasse (1996)
10.1128/jvi.67.9.5299-5302.1993
Monoclonal antibodies that disrupt poliovirus only at fever temperatures.
I Delaet (1993)
10.1038/378743a0
Crystal structure of SIV matrix antigen and implications for virus assembly
Zihe Rao (1995)



This paper is referenced by
10.1128/JVI.00557-08
Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport.
J. Gustav Smith (2008)
10.1016/j.jmb.2009.03.042
Structural Insights into Immune Recognition of the Severe Acute Respiratory Syndrome Coronavirus S Protein Receptor Binding Domain
John Pak (2009)
Mechanism of anti-influenza virus activity of Maillard reaction products derived from Isatidis roots
Lijing Ke (2011)
10.1002/hep.22307
Host neutralizing responses and pathogenesis of hepatitis C virus infection.
Mirjam B Zeisel (2008)
10.1111/j.1750-2659.2010.00192.x
New methods for analyzing serological data with applications to influenza surveillance
Wilfred Ndifon (2011)
10.1016/S2225-4110(16)30070-0
Antiviral Decoction of Isatidis Radix (板藍根 bǎn lán gēn) Inhibited Influenza Virus Adsorption on MDCK Cells by Cytoprotective Activity
Lijing Ke (2012)
10.1371/journal.ppat.1000453
A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes
Bruce S. Thompson (2009)
10.4269/ajtmh.2012.12-0004
Testing of Novel Dengue Virus 2 Vaccines in African Green Monkeys: Safety, Immunogenicity, and Efficacy
Katherine M. Smith (2012)
Environmental Samples Assess the Infectivity of Enteric Viruses in Application of PCR-Based Methods To
Roberto A. Rodríguez (2008)
Visualizing Influenza Virus Membrane Fusion: Inhibition and Kinetics
Jason J Otterstrom (2014)
10.1371/journal.pone.0018437
Vaccine Potential of Nipah Virus-Like Particles
Pramila Walpita (2011)
10.1128/JVI.02189-15
Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry.
Zhiqiang Ku (2015)
10.1586/erv.10.84
Human papillomavirus vaccines in plants
Colomba Giorgi (2010)
Interactions of foot-and-mouth disease virus with cells in organised lymphoid tissue influence innate and adaptive immune responses
Nicholas D Juleff (2009)
10.1128/microbiolspec.AID-0019-2014
Functions of Antibodies.
Donald N Forthal (2014)
Viral Specific Cd8+ T Lymphocyte Immunity Provides Protection Against Heterotypic Stains Of Avian Influenza Viruses And Avian Coronaviruses
Shailbala Singh (2014)
10.1016/j.jviromet.2017.10.022
Colocalization of intracellular specific IgA (icIgA) with influenza virus in patients' nasopharyngeal aspirate cells.
Tuckweng Kok (2018)
10.1038/ni.3680
Defining B Cell Immunodominance to Viruses
Davide Angeletti (2017)
Development and Characterization of Monoclonal Antibodies Directed Against The Canine Parainfluenza Virus Protein
Wenxi He (2019)
10.1007/978-3-030-32459-9
HIV/AIDS: Immunochemistry, Reductionism and Vaccine Design: A Review of 20 Years of Research
Marc H V van Regenmortel (2019)
10.1517/14728214.12.4.525
Monoclonal antibodies for prophylaxis and therapy of infectious diseases
Jan ter Meulen (2007)
10.1080/08830180802593540
Neutralizing Anti-Influenza Virus Monoclonal Antibodies: Therapeutics and Tools for Discovery
Osvaldo García Martínez (2009)
Improvement of foot-and-mouth disease virus vaccines and diagnostics through structural design
Melanie Chitray (2018)
10.1128/JVI.00622-13
Capsid antibodies to different adeno-associated virus serotypes bind common regions.
Brittney L. Gurda (2013)
University of Groningen Mechanisms of Hemagglutinin Targeted Influenza Virus Neutralization
Jarek Juraszek (2013)
10.3389/fimmu.2019.02110
The Roles of Host and Viral Antibody Fc Receptors in Herpes Simplex Virus (HSV) and Human Cytomegalovirus (HCMV) Infections and Immunity
Jennifer A. Jenks (2019)
10.1371/journal.pone.0109391
In Vivo Time-Related Evaluation of a Therapeutic Neutralization Monoclonal Antibody against Lethal Enterovirus 71 Infection in a Mouse Model
Zhiqun Li (2014)
10.1371/journal.pone.0153306
Can VHS Virus Bypass the Protective Immunity Induced by DNA Vaccination in Rainbow Trout?
Dagoberto Sepúlveda (2016)
10.1002/14651858.CD010056.pub2
Post-exposure passive immunisation for preventing measles.
Megan K Young (2014)
10.1038/ncomms7341
A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins
Guntur Fibriansah (2015)
Role of Conserved E 2 Residue W 420 in Receptor Binding and Hepatitis C Virus 1 Infection 2 3
Vanessa Cowton (2016)
10.1017/S1466252313000054
Immunity to bovine herpesvirus 1: II. Adaptive immunity and vaccinology.
Randall L. Levings (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar